Interventional Cardiology
ST-elevation MI treatment and primary PCI
Also called ST elevation MI, primary PCI, STEMI protocol
Sources: updated Oct 1, 2026
Specific, answerable questions in this area — each with its own synthesized evidence and consensus. Open one to see the forest plot, source trials, and how the consensus has changed over time.
Does fibrinolytic therapy vs placebo improve outcomes in ST segment elevation myocardial infarction?
Low CertaintySupports benefitfibrinolytic therapy vs placebo · Myocardial Infarction Hospitalization
Does ticagrelor vs clopidogrel improve Myocardial Infarction Hospitalization in ST segment elevation myocardial infarction?
Low Certaintyticagrelor vs Clopidogrel · Myocardial Infarction Hospitalization
Synthesized from 10 evidence-backed clinical questions on STEMI management — 6 supports benefit, 4 no benefit shown.
The placed evidence leans toward benefit
6
Favor benefit
60% of all
4
No benefit shown
40% of all
Low certainty on 100% of questions
Does ticagrelor vs clopidogrel improve outcomes in Acute Coronary Syndrome?
Low Certainty− No benefit shownticagrelor vs Clopidogrel · Cardiac Output
62 studies (729,408 patients) provide low-certainty evidence against benefit of ticagrelor for Cardiac Output in Acute Coronary Syndrome.
Does ticagrelor vs clopidogrel improve outcomes in ST segment elevation myocardial infarction?
Low Certainty+ Favors benefitticagrelor vs Clopidogrel · Myocardial Infarction Hospitalization
18 studies (206,532 patients) provide low-certainty evidence for benefit of ticagrelor for Myocardial Infarction Hospitalization in ST segment elevation myocardial infarction.
MULTISTARS AMI
UC Riverside Cardiology — Fri, Sep 18, 10:30 AM EDT — 11 attended
CCU #bruinhearts Journal Club: TOMAHAWK
UCLA #bruinhearts Journal Club Section — Tue, Sep 1, 3:00 PM EDT
CCU Journal Club: PLATO Trial
UCLA #bruinhearts Journal Club Section — Tue, Jul 28, 3:00 PM EDT — 5 attended
Sessions from public journal clubs on Synapse. RSVP to join the live discussion.
A clinical question appears here only when its condition matches this topic, an outcome and a comparator were extracted from the studies, at least two studies and a patient count are on file, and the certainty is low or higher.
Supports benefit, no benefit shown, and mixed describe the direction of the measured effect. No benefit shown means the evidence does not support a benefit. It is not a finding of harm. Too little evidence means the question did not clear that bar.
Study count, RCT count, and patient count are separate. The patient total adds only studies that are linked into a study family and whose sample size is not flagged as implausible. A reversal is listed only when at least one randomized trial sits on each side of the change.
The overview is drafted from the guideline recommendations, trials, papers, and questions on this page, and every sentence has to cite one of them. It stays unverified until an NPI-verified clinician or a Synapse admin approves it. Approving records that person's name.